Greenebaum Cancer Center - Clinical Trials

  Clinical Trials...
     More About Clinical Trials
     Participating
     Questions to Ask
     For More Information
  Research
  Cancer Overviews
  Treatment Programs
  Physicians and Staff

Current Clinical Trials for Waldenstrom's Macroglobulinemia

GCC 0908 - An Open-Label, Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.